nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketoprofen—Atomoxetine—SLC6A4—conduct disorder	0.15	0.565	CrCbGaD
Ketoprofen—Atomoxetine—HTR2A—conduct disorder	0.115	0.434	CrCbGaD
Ketoprofen—CXCR1—GPCRs, Other—DRD4—conduct disorder	0.0485	0.0659	CbGpPWpGaD
Ketoprofen—CXCL8—Glucocorticoid receptor regulatory network—CGA—conduct disorder	0.0424	0.0577	CbGpPWpGaD
Ketoprofen—CXCR1—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.0322	0.0438	CbGpPWpGaD
Ketoprofen—CXCR1—GPCRs, Other—HTR2A—conduct disorder	0.0316	0.043	CbGpPWpGaD
Ketoprofen—CXCR1—GPCR ligand binding—CGA—conduct disorder	0.0245	0.0334	CbGpPWpGaD
Ketoprofen—CXCR1—G alpha (i) signalling events—DRD4—conduct disorder	0.0227	0.0308	CbGpPWpGaD
Ketoprofen—CXCR1—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.021	0.0286	CbGpPWpGaD
Ketoprofen—CXCR1—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.018	0.0245	CbGpPWpGaD
Ketoprofen—CXCL8—Validated transcriptional targets of AP1 family members Fra1 and Fra2—EP300—conduct disorder	0.0155	0.0211	CbGpPWpGaD
Ketoprofen—CXCL8—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.0151	0.0206	CbGpPWpGaD
Ketoprofen—CXCL8—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.0145	0.0198	CbGpPWpGaD
Ketoprofen—CXCR1—GPCR downstream signaling—CGA—conduct disorder	0.0139	0.0188	CbGpPWpGaD
Ketoprofen—CXCR1—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.0137	0.0187	CbGpPWpGaD
Ketoprofen—CXCR1—GPCR ligand binding—DRD4—conduct disorder	0.0137	0.0187	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling by GPCR—CGA—conduct disorder	0.0126	0.0171	CbGpPWpGaD
Ketoprofen—ABCC4—NRF2 pathway—SLC6A4—conduct disorder	0.0125	0.017	CbGpPWpGaD
Ketoprofen—CXCR1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.0118	0.016	CbGpPWpGaD
Ketoprofen—CXCL8—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.0114	0.0155	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR ligand binding—CGA—conduct disorder	0.0111	0.0151	CbGpPWpGaD
Ketoprofen—PTGS1—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.0109	0.0149	CbGpPWpGaD
Ketoprofen—CXCL8—ATF-2 transcription factor network—EP300—conduct disorder	0.0107	0.0145	CbGpPWpGaD
Ketoprofen—CXCL8—G alpha (i) signalling events—DRD4—conduct disorder	0.0102	0.0139	CbGpPWpGaD
Ketoprofen—CXCL8—AP-1 transcription factor network—EP300—conduct disorder	0.00932	0.0127	CbGpPWpGaD
Ketoprofen—CXCL8—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.00927	0.0126	CbGpPWpGaD
Ketoprofen—CXCR1—GPCR ligand binding—HTR2A—conduct disorder	0.00896	0.0122	CbGpPWpGaD
Ketoprofen—SLC22A11—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00861	0.0117	CbGpPWpGaD
Ketoprofen—CXCL8—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—conduct disorder	0.00838	0.0114	CbGpPWpGaD
Ketoprofen—CXCL8—Glucocorticoid receptor regulatory network—EP300—conduct disorder	0.00822	0.0112	CbGpPWpGaD
Ketoprofen—CXCL8—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00814	0.0111	CbGpPWpGaD
Ketoprofen—SLC22A7—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00781	0.0106	CbGpPWpGaD
Ketoprofen—CXCL8—Metabolism of proteins—CGA—conduct disorder	0.00779	0.0106	CbGpPWpGaD
Ketoprofen—CXCR1—GPCR downstream signaling—DRD4—conduct disorder	0.00776	0.0106	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—CGA—conduct disorder	0.00743	0.0101	CbGpPWpGaD
Ketoprofen—CYP2C8—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00706	0.0096	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling by GPCR—DRD4—conduct disorder	0.00705	0.00958	CbGpPWpGaD
Ketoprofen—SLC22A8—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00656	0.00893	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00654	0.00889	CbGpPWpGaD
Ketoprofen—ABCC4—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00629	0.00856	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR downstream signaling—CGA—conduct disorder	0.00625	0.00851	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR ligand binding—DRD4—conduct disorder	0.0062	0.00843	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—WASF1—conduct disorder	0.00596	0.0081	CbGpPWpGaD
Ketoprofen—PTGS1—Biological oxidations—COMT—conduct disorder	0.00584	0.00795	CbGpPWpGaD
Ketoprofen—SLCO1A2—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00583	0.00793	CbGpPWpGaD
Ketoprofen—PTGS1—Biological oxidations—MAOA—conduct disorder	0.0058	0.00789	CbGpPWpGaD
Ketoprofen—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00574	0.00781	CbGpPWpGaD
Ketoprofen—PTGS2—Aryl Hydrocarbon Receptor—EP300—conduct disorder	0.00571	0.00777	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—CGA—conduct disorder	0.00568	0.00772	CbGpPWpGaD
Ketoprofen—SLC22A6—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00548	0.00745	CbGpPWpGaD
Ketoprofen—CXCL8—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00531	0.00722	CbGpPWpGaD
Ketoprofen—CXCR1—GPCR downstream signaling—HTR2A—conduct disorder	0.00506	0.00689	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00497	0.00676	CbGpPWpGaD
Ketoprofen—CXCL8—SIDS Susceptibility Pathways—EP300—conduct disorder	0.00491	0.00668	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling by GPCR—HTR2A—conduct disorder	0.0046	0.00625	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—DRD4—conduct disorder	0.00416	0.00566	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR ligand binding—HTR2A—conduct disorder	0.00404	0.0055	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00395	0.00537	CbGpPWpGaD
Ketoprofen—CYP2C8—Biological oxidations—COMT—conduct disorder	0.00378	0.00513	CbGpPWpGaD
Ketoprofen—CYP2C8—Biological oxidations—MAOA—conduct disorder	0.00375	0.0051	CbGpPWpGaD
Ketoprofen—CYP2C8—Metapathway biotransformation—COMT—conduct disorder	0.00372	0.00506	CbGpPWpGaD
Ketoprofen—PTGS2—C-MYB transcription factor network—EP300—conduct disorder	0.00353	0.0048	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR downstream signaling—DRD4—conduct disorder	0.0035	0.00476	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—CGA—conduct disorder	0.00336	0.00456	CbGpPWpGaD
Ketoprofen—CXCL8—Cellular responses to stress—EP300—conduct disorder	0.00322	0.00438	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00321	0.00437	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00319	0.00434	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—DRD4—conduct disorder	0.00318	0.00433	CbGpPWpGaD
Ketoprofen—CYP2C9—Biological oxidations—COMT—conduct disorder	0.00307	0.00418	CbGpPWpGaD
Ketoprofen—CYP2C9—Biological oxidations—MAOA—conduct disorder	0.00305	0.00415	CbGpPWpGaD
Ketoprofen—CYP2C9—Metapathway biotransformation—COMT—conduct disorder	0.00303	0.00412	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—CGA—conduct disorder	0.00291	0.00396	CbGpPWpGaD
Ketoprofen—ALB—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00285	0.00387	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—HTR2A—conduct disorder	0.00272	0.00369	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—WASF1—conduct disorder	0.00269	0.00366	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00261	0.00355	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR downstream signaling—HTR2A—conduct disorder	0.00229	0.00311	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—CGA—conduct disorder	0.00221	0.00301	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—HTR2A—conduct disorder	0.00208	0.00282	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—DRD4—conduct disorder	0.00188	0.00256	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.00183	0.00249	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—CGA—conduct disorder	0.00176	0.00239	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—EP300—conduct disorder	0.0015	0.00204	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—EP300—conduct disorder	0.00144	0.00196	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—CGA—conduct disorder	0.00143	0.00195	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—CGA—conduct disorder	0.00142	0.00193	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—COMT—conduct disorder	0.00131	0.00179	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—MAOA—conduct disorder	0.0013	0.00177	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.00127	0.00172	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—HTR2A—conduct disorder	0.00123	0.00167	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—CGA—conduct disorder	0.00116	0.00158	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—COMT—conduct disorder	0.001	0.00136	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—MAOA—conduct disorder	0.000992	0.00135	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000962	0.00131	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—COMT—conduct disorder	0.000793	0.00108	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—MAOA—conduct disorder	0.000788	0.00107	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000764	0.00104	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—EP300—conduct disorder	0.000679	0.000923	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—EP300—conduct disorder	0.00065	0.000883	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—COMT—conduct disorder	0.000646	0.000878	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—COMT—conduct disorder	0.000642	0.000873	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—MAOA—conduct disorder	0.000641	0.000872	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—MAOA—conduct disorder	0.000637	0.000867	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000622	0.000845	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000618	0.000841	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—EP300—conduct disorder	0.000563	0.000766	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—COMT—conduct disorder	0.000525	0.000715	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—MAOA—conduct disorder	0.000522	0.00071	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000506	0.000688	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—EP300—conduct disorder	0.000429	0.000583	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—EP300—conduct disorder	0.000406	0.000553	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—EP300—conduct disorder	0.00034	0.000463	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—EP300—conduct disorder	0.000277	0.000377	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—EP300—conduct disorder	0.000275	0.000374	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—EP300—conduct disorder	0.000225	0.000306	CbGpPWpGaD
